Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

Ke Chen, Lu Gao, Yu Liu, Yan Zhang, Ding Sheng Jiang, Xiang Wei, Xue Hai Zhu, Rui Zhang, Yingjie Chen, Qinglin Yang, Noriyuki Kioka, Xiao Dong Zhang, Hongliang Li

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Cardiac hypertrophy is the heart's response to hypertrophic stimuli and is associated with increased mortality. Vinexin-β is a vinculin-binding protein that belongs to a family of adaptor proteins and mediates signal transduction and actin cytoskeleton organisation. A previous study has shown that Vinexin-β is ubiquitously expressed and that it is highly expressed in the heart. However, a critical role for Vinexin-β in cardiac hypertrophy has not been investigated. Therefore, to examine the role of Vinexin-β in pathological cardiac hypertrophy, we used Vinexin-β knockout mice and transgenic mice that overexpress human Vinexin-β in the heart. Cardiac hypertrophy was induced by aortic banding (AB). The extent of cardiac hypertrophy was quantitated by echocardiography and pathological and molecular analyses of heart samples. Our results demonstrated that Vinexin-β overexpression in the heart markedly attenuated cardiac hypertrophy, fibrosis, and cardiac dysfunction, whereas loss of Vinexin-β exaggerated the pathological cardiac remodelling and fibrosis response to pressure overload. Further analysis of the in vitro and in vivo signalling events indicated that beneficial Vinexin-β effects were associated with AKT signalling abrogation. Our findings demonstrate for the first time that Vinexin-β is a novel mediator that protects against cardiac hypertrophy by blocking the AKT signalling pathway.

Original languageEnglish (US)
Article number338
JournalBasic research in cardiology
Volume108
Issue number2
DOIs
StatePublished - Jan 1 2013

Keywords

  • AKT
  • Cardiac remodelling
  • Hypertrophy
  • Vinexin-β

Fingerprint Dive into the research topics of 'Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway'. Together they form a unique fingerprint.

  • Cite this

    Chen, K., Gao, L., Liu, Y., Zhang, Y., Jiang, D. S., Wei, X., Zhu, X. H., Zhang, R., Chen, Y., Yang, Q., Kioka, N., Zhang, X. D., & Li, H. (2013). Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic research in cardiology, 108(2), [338]. https://doi.org/10.1007/s00395-013-0338-0